Caenorhabditis elegans DAF-2 as a Model for Human Insulin Receptoropathies

G3: Genes, Genomes, Genetics

Volumn 7, Issue 1, 2017, Pages 257-268

  Bulger, David A ^a,b   Fukushige, Tetsunari ^a   Yun, Sijung ^a   Semple, Robert K ^b   Hanover, John A ^a   Krause, Michael W ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CRISPR; DAF 2; Dauer; INSR; Million Mutation Project

Indexed keywords

INSULIN RECEPTOR; CAENORHABDITIS ELEGANS PROTEIN; DAF-2 PROTEIN, C ELEGANS; INSULIN;

ALLELE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CRISPR CAS SYSTEM; DAF 2 GENE; FUNGAL STRAIN; GENE MUTATION; GENE REPLICATION; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; RECEPTOR GENE; SIGNAL TRANSDUCTION; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; LONGEVITY; METABOLISM; MUTATION;

AMINO ACID SUBSTITUTION; ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INSULIN; LONGEVITY; MUTATION; RECEPTOR, INSULIN;

EID: 85008471579     PISSN: None     EISSN: 21601836     Source Type: Journal    
DOI: 10.1534/g3.116.037184     Document Type: Article

References (45)

1. Adzhubei, I. A., S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova et al., 2010 A method and server for predicting damaging missense mutations. Nat. Methods 7: 248-249.
2. Ailion, M., and J. H. Thomas, 2003 Isolation and characterization of hightemperature-induced dauer formation mutants in Caenorhabditis elegans. Genetics 165: 127-144.
3. Arribere, J. A., R. T. Bell, B. X. Fu, K. L. Artiles, P. S. Hartman et al., 2014 Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans. Genetics 198: 837-846.
4. Berman, H. M., T. Battistuz, T. N. Bhat, W. F. Bluhm, P. E. Bourne et al., 2002 The protein data bank. Acta Crystallogr. D Biol. Crystallogr. 58: 899-907.
5. Brooks, B. R., C. L. Brooks, III, A. D. Mackerell, Jr., L. Nilsson, R. J. Petrella et al., 2009 CHARMM: the biomolecular simulation program. J. Comput. Chem. 30: 1545-1614.
6. Cama, A., M. de la Luz Sierra, M. J. Quon, L. Ottini, P. Gorden et al., 1993 Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity. J. Biol. Chem. 268: 8060-8069.
7. Choi, Y., G. E. Sims, S. Murphy, J. R. Miller, and A. P. Chan, 2012 Predicting the functional effect of amino acid substitutions and indels. PLoS One 7: e46688.
8. Christensen, K., T. E. Johnson, and J. W. Vaupel, 2002 The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7: 436-448.
9. De Meyts, P., and J. Whittaker, 2002 Structural biology of insulin and IGF1 receptors: implications for drug design. Nat. Rev. Drug Discov. 1: 769-783.
10. Dickinson, D. J., J. D.Ward, D. J. Reiner, and B. Goldstein, 2013 Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat. Methods 10: 1028-1034.
11. Gems, D., A. J. Sutton, M. L. Sundermeyer, P. S. Albert, K. V. King et al., 1998 Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150: 129-155.
12. Goldschneider, D., and P. Mehlen, 2010 Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29: 1865-1882.
13. Gottlieb, S., and G. Ruvkun, 1994 daf-2, daf-16 and daf-23: genetically interacting genes controlling dauer formation in Caenorhabditis elegans. Genetics 137: 107-120.
14. Hicks, S., D. A. Wheeler, S. E. Plon, and M. Kimmel, 2011 Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum. Mutat. 32: 661-668.
15. Hongo, A., G. Yumet, M. Resnicoff, G. Romano, R. O'Connor et al., 1998 Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res. 58: 2477-2484.
16. Howe, K. L., B. J. Bolt, S. Cain, J. Chan, W. J. Chen et al., 2016 Worm-Base 2016: expanding to enable helminth genomic research. Nucleic Acids Res. 44: D774-D780.
17. Hu, P. J., 2007 Dauer. WormBook 8: 1-19.
18. Kadowaki, T., C. L. Bevins, A. Cama, K. Ojamaa, B. Marcus-Samuels et al., 1988 Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787-790.
19. Kimura, K. D., H. A. Tissenbaum, Y. Liu, and G. Ruvkun, 1997 daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946.
20. Krause, M., and D. Hirsh, 1987 A trans-spliced leader sequence on actin mRNA in C. elegans. Cell 49: 753-761.
21. Kumar, P., S. Henikoff, and P. C. Ng, 2009 Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4: 1073-1081.
22. Lee, H., M. K. Choi, D. Lee, H. S. Kim, H. Hwang et al., 2011 Nictation, a dispersal behavior of the nematode Caenorhabditis elegans, is regulated by IL2 neurons. Nat. Neurosci. 15: 107-112.
23. Lindhurst, M. J., V. E. Parker, F. Payne, J. C. Sapp, S. Rudge et al., 2012 Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA. Nat. Genet. 44: 928-933.
24. Liu, Y., S. Lehar, C. Corvi, G. Payne, and R. O'Connor, 1998 Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells. Cancer Res. 58: 570-576.
25. Malone, E. A., and J. H. Thomas, 1994 A screen for nonconditional dauerconstitutive mutations in Caenorhabditis elegans. Genetics 136: 879-886.
26. Manning, G., D. B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, 2002 The protein kinase complement of the human genome. Science 298: 1912-1934.
27. Moreira, R. O., R. L. Zagury, T. S. Nascimento, and L. Zagury, 2010 Multidrug therapy in a patient with Rabson-Mendenhall syndrome. Diabetologia 53: 2454-2455.
28. Morgenstern, B., S. J. Prohaska, D. Pohler, and P. F. Stadler, 2006 Multiple sequence alignment with user-defined anchor points. Algorithms Mol. Biol. 1: 6.
29. Ng, P. C., and S. Henikoff, 2006 Predicting the effects of amino acid substitutions on protein function. Annu. Rev. Genomics Hum. Genet. 7: 61-80.
30. O'Connor, R., A. Kauffmann-Zeh, Y. Liu, S. Lehar, G. I. Evan et al., 1997 Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17: 427-435.
31. Ogg, S., and G. Ruvkun, 1998 The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2: 887-893.
32. Paix, A., Y. Wang, H. E. Smith, C. Y. Lee, D. Calidas et al., 2014 Scalable and versatile genome editing using linear DNAs with microhomology to Cas9 sites in Caenorhabditis elegans. Genetics 198: 1347-1356.
33. Patel, D. S., A. Garza-Garcia, M. Nanji, J. J. McElwee, D. Ackerman et al., 2008 Clustering of genetically defined allele classes in the Caenorhabditis elegans DAF-2 insulin/IGF-1 receptor. Genetics 178: 931-946.
34. Poltilove, R. M., A. R. Jacobs, C. R. Haft, P. Xu, and S. I. Taylor, 2000 Characterization of Drosophila insulin receptor substrate. J. Biol. Chem. 275: 23346-23354.
35. Semple, R. K., 2016 EJE PRIZE 2015: how does insulin resistance arise, and how does it cause disease? human genetic lessons. Eur. J. Endocrinol. 174: R209-R223.
36. Semple, R. K., D. B. Savage, E. K. Cochran, P. Gorden, and S. O'Rahilly, 2011 Genetic syndromes of severe insulin resistance. Endocr. Rev. 32: 498-514.
37. Semple, R. K., D. B. Savage, G. V. Brierley, and S. O'Rahilly, 2016 Chapter 22-syndromes of severe insulin resistance and/or lipodystrophy, pp. 307-324 in Genetic Diagnosis of Endocrine Disorders, Ed. 2, edited by Weiss, R. E., and S. Refetoff. Academic Press, San Diego.
38. Taly, J. F., C. Magis, G. Bussotti, J. M. Chang, P. Di Tommaso et al., 2011 Using the T-Coffee package to build multiple sequence alignments of protein, RNA, DNA sequences and 3D structures. Nat. Protoc. 6: 1669-1682.
39. Taniguchi, C. M., B. Emanuelli, and C. R. Kahn, 2006 Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7: 85-96. 10.1038/nrm1837.
40. Taylor, S. I., 1992 Lilly lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41: 1473-1490.
41. Taylor, S. I., A. Cama, D. Accili, F. Barbetti, M. J. Quon et al., 1992 Mutations in the insulin receptor gene. Endocr. Rev. 13: 566-595.
42. Thompson, O., M. Edgley, P. Strasbourger, S. Flibotte, B. Ewing et al., 2013 The million mutation project: a new approach to genetics in Caenorhabditis elegans. Genome Res. 23: 1749-1762.
43. Wheeler, D. L., and Y. Yarden (Editors), 2015 Receptor Tyrosine Kinases: Structure, Functions and Role in Human. Humana Press Springer, New York.
44. Wolkow, C. A., M. J. Munoz, D. L. Riddle, and G. Ruvkun, 2002 Insulin receptor substrate and p55 orthologous adaptor proteins function in the Caenorhabditis elegans daf-2/insulin-like signaling pathway. J. Biol. Chem. 277: 49591-49597.
45. Zhang, Y., 2008 I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9: 40. 10.1186/1471-2105-9-40.